Drugs / MSSM/BIIR HDC Vax-001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00935597 | Aug 2009 → Jul 2013 | Hodgkins lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, plasma cell myeloma | Icahn School of Medicine at Mount Sinai | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MSSM/BIIR HDC Vax-001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00935597 ↗ |
| Route | Other | “by infusion” NCT00935597 ↗ |